Diabetes News and Research

Latest Diabetes News and Research

Diamyd Medical announces European Phase III study results in type 1 diabetes

Diamyd Medical reports that results from its European Phase III study with the antigen-based therapy Diamyd did not meet the primary efficacy endpoint of preserving beta cell function at 15 months, as measured by meal stimulated C-peptide, in newly diagnosed type 1 diabetes patients.

9 May 2011

Elan Drug Technologies, Alkermes merge to form new company in Ireland

Alkermes, Inc. and Elan Corporation, plc today announced the execution of a definitive agreement under which Alkermes will merge with Elan Drug Technologies, the profitable, world-class drug formulation and manufacturing business unit of Elan, in a cash and stock transaction currently valued at approximately $960 million.

9 May 2011

Innovative detection practices may prevent liver diseases

Research being presented at Digestive Disease Week- shows that screening individuals for hepatitis C based on age instead of conventional risk factors may help increase detection rates as well as prevent liver disease.

9 May 2011

Junk food ads to be banned to slow childhood obesity rates

Health experts and anti-obesity groups have called for a total ban on junk-food advertising during peak children's viewing times. This comes in the wake of the release of the research finding of the Obesity Policy Coalition that conducted a telephone survey of 1,521 adults says that 84 per cent of consumers believe children should be protected from unhealthy food advertising.

8 May 2011

Study provides information about hematuria in microscopic urinalysis and urinary tract cancer

Hematuria or blood in the urine may trigger a battery of tests for urinary tract cancer that are invasive and can unnecessarily expose patients to radiation, yet the procedures contribute little to the diagnosis, according to a study by Kaiser Permanente Southern California's Department of Research & Evaluation published in the May issue of the Journal of Urology.

7 May 2011

Urgent action needed to avoid preventable strokes in Asia-Pacific region, says new report

Experts from medical and patient communities call on national policymakers in the Asia-Pacific region to take urgent action against preventable strokes that strike millions of people with atrial fibrillation each year.

7 May 2011

ESC Heart Failure meeting offers strong scientific programme

This year the Heart Failure Congress 2011, organised by the Heart Failure Association of the European Society of Cardiology, offers a strong scientific programme featuring 11 late breaking trials and clinical updates, over 1000 original abstracts, 14 industry sponsored satellites and mini satellites and over 70 separate sessions.

7 May 2011

Millennium presents VELCADE Phase III trial data in multiple myeloma at IMW meeting

Millennium: The Takeda Oncology Company today reported the presentation of results of a randomized Phase III trial that investigated the effect of consolidation with single-agent VELCADE for Injection in newly diagnosed multiple myeloma patients after autologous stem cell transplant.

7 May 2011

AGA's cutting-edge research on GI disorders to be presented at DDW 2011

Clinicians, researchers and scientists from around the world will gather for Digestive Disease Week- 2011, the largest and most prestigious gastroenterology meeting, from May 7-10, 2011, at McCormick Place, Chicago, IL.

7 May 2011

Halozyme Therapeutics reports net loss of $9.6 million for first quarter 2011

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets, today reported financial results for the first quarter 2011.

7 May 2011

Research roundup: Racial disparities in cancer screening and VA treatment

Racial And Ethnic Disparities In Colorectal Cancer Screening Persisted Despite Expansion Of Medicare's Screening Reimbursement. This study looked at the effect in minority groups of expanded reimbursements by Medicare for colorectal cancer screenings.

7 May 2011

Spherix effects 1-for-10 reverse stock split

Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it has filed a Certificate of Amendment to its Certificate of Incorporation, as amended, to effect a 1-for-10 reverse stock split of its common stock that will become effective at end of business today.

7 May 2011

Roche seeks FDA clearance for fully automated Chlamydia and gonorrhoeae test

Roche announced today that it has filed for FDA clearance of its Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) tests.

7 May 2011

First Edition: May 6, 2011

Today's headlines indicate that the GOP may be rethinking its plans to revamp Medicare -- especially as a new round of debt accord talks begin between Vice President Joe Biden and congressional leaders.

6 May 2011

Workload, time constraints hold nurses to lead global fight against non-communicable diseases

Nurses want to lead in the global fight against the further spread of non-communicable diseases but workload and time constraints are holding them back, according to a major new survey by the International Council of Nurses and Pfizer.

6 May 2011

New project to explore European diet and healthy ageing

People are living longer. Rising living standards, improved lifestyle and better education, as well as greater access to quality healthcare services has meant that we can expect to reach 78 years of age, an increase of six years compared to the 1980s. However, data also shows that Europeans live to just over 60 years without being limited in their day-to-day activities by ill-health or disabilities.

6 May 2011

Shenzhen Wuzhou International introduces wide range of portable monitors and testers

People have become more and more intent on enjoying convenience at communal facilities and getting more services in food, clothing, housing, and transport. However, it is still very difficult for sick people to get timely and easy diagnosis.

6 May 2011

Millennium presents three studies in relapsed multiple myeloma at IMW meeting

Millennium: The Takeda Oncology Company today reported results from three studies in relapsed multiple myeloma. Two of the studies examined the use of VELCADE for Injection; the third study presents clinical data on MLN9708, the first investigational oral proteasome inhibitor.

6 May 2011

Targeting Aurora A gene could halt rhabdoid tumor growth in children

There are no effective treatments for rhabdoid tumors - aggressive childhood cancers that usually strike children under three years old and affect the brain or kidneys. The disease is extremely rare - fewer than 10 cases are diagnosed each year in the U.S. - but is particularly difficult to treat and almost always fatal.

6 May 2011

Viewpoints: Gov. Daniels's reversal?; IPAB's Medicare fix; Texas Medicaid cuts

Centrist Republicans loved it when began urging the party to keep its eye on the deficit-reduction prize and stop obsessing about social issues. ... He then went home and announced that he would sign a bill to strip Planned Parenthood of Medicaid financing. ... Daniels's moderate fans thought abortion was precisely the issue he was calling on Republicans to set aside. Right now, the new Republican majority in the House of Representatives can barely talk about anything else.

6 May 2011

Diabetes News and Research

Latest Diabetes News and Research

Diamyd Medical announces European Phase III study results in type 1 diabetes

Elan Drug Technologies, Alkermes merge to form new company in Ireland

Innovative detection practices may prevent liver diseases

Junk food ads to be banned to slow childhood obesity rates

Study provides information about hematuria in microscopic urinalysis and urinary tract cancer

Urgent action needed to avoid preventable strokes in Asia-Pacific region, says new report

ESC Heart Failure meeting offers strong scientific programme

Millennium presents VELCADE Phase III trial data in multiple myeloma at IMW meeting

AGA's cutting-edge research on GI disorders to be presented at DDW 2011

Halozyme Therapeutics reports net loss of $9.6 million for first quarter 2011

Research roundup: Racial disparities in cancer screening and VA treatment

Spherix effects 1-for-10 reverse stock split

Roche seeks FDA clearance for fully automated Chlamydia and gonorrhoeae test

First Edition: May 6, 2011

Workload, time constraints hold nurses to lead global fight against non-communicable diseases

New project to explore European diet and healthy ageing

Shenzhen Wuzhou International introduces wide range of portable monitors and testers

Millennium presents three studies in relapsed multiple myeloma at IMW meeting

Targeting Aurora A gene could halt rhabdoid tumor growth in children

Viewpoints: Gov. Daniels's reversal?; IPAB's Medicare fix; Texas Medicaid cuts

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Diabetes News and Research

Latest Diabetes News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in